Risk Stratification of Newly Diagnosed Prostate Cancer with Genomic Platforms

Conclusions Risk stratification tools incorporating genomic analysis of prostate cancer have been developed which seek to improve the accuracy of initial predictions. Further study is warranted to define the additive clinical benefit associated with their use if implemented broadly. (Source: Urology Practice)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2rNl2EP
via IFTTT